Delivery Order SPE2DB22D2206-SPE2DB24FGY50
- Not listed
- This federal contract award, valued at $85,025.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a completion date of November 8, 2023. The contract is a delivery order and has a firm fixed price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and...
- This federal contract award, valued at $2,387.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 6, 2023 and is a Firm Fixed Price Delivery Order contract. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $12,177.00 for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award, valued at $16,886.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MENVEO A-C-Y-W Kits, a type of vaccine, with a completion date of January 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $3,769.68 firm fixed-price delivery order is for the provision of 4554306395 MENVEO A-C-Y-W-135-DIP VIAL KTS, a pharmaceutical product. The contract has an ultimate completion date of August 4, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,023.35, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is November 7, 2023. This award is not associated with a set-aside designation,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.48, is a delivery order for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML". The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $116,040.40 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceuticals with a performance period through March 15, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to...
- This federal contract award, valued at $6,153.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
- This federal contract award, valued at $18,353.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a performance period ending on August 11, 2023. The contract has a Firm Fixed Price pricing type and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a for-profit...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGY50Delivery Order
This federal contract award, valued at $23,232.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a medical product, with a period of performance ending on May 1, 2024. The contract is a firm fixed-price arrangement and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense healthcare needs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.2k | 4/30/24 |